Main results for effects on mini-HEI and BMI z-scores, and SSB, FV and Fish z-scores, for age group 14y9m. by Anne Ahrendt Bjerregaard (7377500)

Main results for effects on mini-HEI and BMI z-scores, and SSB, FV and Fish z-scores, for baseline dietstratum 1 where the tailored SMS program targeted Fish. by Anne Ahrendt Bjerregaard (7377500)

Effects of the SMS program on the mini-HEI and on the BMI z-scores. by Anne Ahrendt Bjerregaard (7377500)

Patient characteristics of individuals referred to or evaluated by a cystic fibrosis-gastrointestinal clinic. by Nicha Wongjarupong (4671181)

Effect of Amphiphilic CaCO₃ Nanoparticles on the Plant Surfactant Saponin Solution on the Oil–Water Interface: A Feasibility Research of Enhanced Oil Recovery by Kaiping Tian (16834391)

D-4F and L-5F improves blood glucose. by Kristine C. McGrath (8269155)

DataSheet_1_METTL3-Mediated N6-Methyladenosine Modification of Trim59 mRNA Protects Against Sepsis-Induced Acute Respiratory Distress Syndrome.docx by Yi Chen (38576)

“…Furthermore, we identified tripartite motif-containing (Trim)59 as a key m⁶A effector and Trim59 deficiency exacerbated lung injury. …”

αHT compound 390 does not affect intracellular capsid accumulation or encapsidated HBV RNA levels in HepG2.2.15 cells. by Daniel P. Bradley (10306893)

Subjects:

1466 does not change total yield of capsids during biochemical assembly reactions. by Daniel P. Bradley (10306893)

Subjects:

HPD compounds 1736 and 1740 also suppress accumulation of HBV capsids. by Daniel P. Bradley (10306893)

Subjects:

Compound 390 induces HBV capsid accumulation via an ROS-mediated mechanism. by Daniel P. Bradley (10306893)

Subjects:

HBV RNaseH inhibitors effects on capsid accumulation occur independent of HBV DNA synthesis. by Daniel P. Bradley (10306893)

Subjects:

1466 slows the capsid assembly rate in biochemical Cp149 capsid assembly reactions. by Daniel P. Bradley (10306893)

Subjects:

Differences among the classes of CAMs. by Daniel P. Bradley (10306893)

Subjects:

HBV replication cycle with modeled activity of 1466, a bimodal HBV RNaseH-CAM-I Inhibitor, and other small molecule inhibitors used in this study. by Daniel P. Bradley (10306893)

Subjects:

Compound structures and preferential inhibition of the HBV plus-polarity DNA strand. by Daniel P. Bradley (10306893)

Subjects:

1466 does not induce disassembly of pre-formed HBV capsids in cell lysates. by Daniel P. Bradley (10306893)

Subjects:

1466 inhibits capsid accumulation independent of HBV replication. by Daniel P. Bradley (10306893)

Subjects:

Screening HBV RNaseH inhibitors in HepDES19 cell for effects on capsids and core protein. by Daniel P. Bradley (10306893)

Subjects:

Effects of 1466 on capsid and pgRNA encapsidation compared to known CAM-A and CAM-E inhibitors. by Daniel P. Bradley (10306893)

Subjects: